Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease

Biological Trace Element Research

Volumn 158, Issue 2, 2014, Pages 158-165

  Krishnan, Sreeram ^a   Rani, P ^a  

^a PSG COLLEGE OF TECHNOLOGY   (India)

Author keywords

Alzheimer's disease; Amyloid; Lipid peroxidation; Oxidative stress; Selenium; Tau; Vascular dementia

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PROTEIN; ENZYME; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; SELENIUM; SELENOENZYME; TAU PROTEIN; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); ANTIOXIDANT; PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ANALYTICAL PARAMETERS; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ENZYME ACTIVITY; FEMALE; HUMAN; INDIA; LIPID PEROXIDATION; MALE; MINI MENTAL STATE EXAMINATION; MOLECULAR PATHOLOGY; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; SELENIUM BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TAU TO AMYLOID RATIO; BLOOD; MIDDLE AGED; OXIDATION REDUCTION REACTION;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTIOXIDANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; SELENIUM; TAU PROTEINS;

EID: 84899628999     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-014-9930-x     Document Type: Article

References (40)

1. Shaji KS, Jotheeswaran AT, Girish N, et al (2010) Dementia India Report: prevalence, impact, costs and services for dementia. Alzheimer's & Related Disorders Society of India. http://www.alzheimer.org.in/assets/dementia.pdf. Accessed 25 Aug 2013
2. Zawia NH, Lahiri DK, Cardozo-Pelaez F (2009) Epigenetics, oxidative stress and Alzheimer's disease. Free Readic Biol Med 46:1241-1249
3. Padurariu M, Ciobica A, Hritcu L et al (2010) Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer 's disease. Neurosci Lett 469:6-10
4. Butterfield DA, Swomley AM, Sultana R (2013) Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signal 19:823-835
5. Puertas MC, Martinez-Martos JM, Cobo MP et al (2012) Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia. Exp Gerontol 47:625-630
6. Casado A, Lopez-Fernandez ME, Casado MC et al (2008) Lipid peroxidation and antioxidant enzyme activities in vascular dementia and Alzheimer dementias. Neurochem Res 33:450-458 (Pubitemid 351230446)
7. NaziroǧluM(2007) New molecular mechanisms on the activation of TRPM2 channels by oxidative stress and ADP-ribose. Neurochem Res 32:1990-2001
8. 2+ signalling and TRP channel activation in nervous system. J Recept Signal Transduct Res 32:134-141
9. Naziroǧlu M, Yürekli VA (2013) Effects of antiepileptic drugs on antioxidant and oxidantmolecular pathways: focus on trace elements. Cell Mol Neurobiol 33:589-599
10. Gwon AR, Park JS, Park JH et al (2010) Selenium attenuates A beta production and A beta-induced neuronal death. Neurosci Lett 469:391-395
11. Steinbrenner H, Sies H (2013) Selenium homeostasis and antioxidant selenoproteins in brain: implications for disorders in the central nervous system. Arch Biochem Biophys 536:152-157
12. Akbaraly NT, Hininger-Favier I, Carriere I et al (2007) Plasma selenium over time and cognitive decline in the elderly. Epidemiology 18:52-58 (Pubitemid 46005909)
13. Loef M, Schrauzer GN, Walach H (2011) Selenium and Alzheimer's disease: a systematic review. J Alzheimers Dis 26:81-104
14. Kapaki E, Paraskevas GP, Zalonis I et al (2003) CSF tau protein and beta-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population. Eur J Neurol 10:119-128 (Pubitemid 36308205)
15. Mayeux R, Honig LS, TangMX et al (2003) Plasma Aβ40 and Aβ42 and Alzheimer's disease. Relation to age, mortality and risk. Neurology 61:1185-1190
16. Sparks DL, Kryscio RJ, Sabbagh MN et al (2012) Tau is reduced in AD plasma and validation of employed ELISA methods. Am J Neurodegener Dis 1:99-106
17. Sunderland T, Linker G, Mirza N et al (2003) Decreased β amyloid 1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer 's disease. JAMA 289:2094-2103 (Pubitemid 37430211)
18. Rice-Evans C (1996) Free radicals and antioxidants in atherosclerosis. In: Blake D, Winyard PG (eds) Immunopharmacology of free radical species. Academic, London, pp 39-52
19. Folstein MF, Folstein SE, Mc Hugh PR (1975) "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
20. Rani P, Unni M, Karthikeyan J (2004) Evaluation of antioxidant properties of berries. Indian J Clin Biochem 19:103-110 (Pubitemid 39050238)
21. Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
22. Drabkin DL, Austin JH (1935) Spectrophotometric studies II. Preparations from washed blood cells; nitric oxide haemoglobin and sulfhaemoglobin. J Biol Chem 112:51-65
23. Safaralizadeh R, Kardar GA, Pourpak Z et al (2005) Serum concentrations of selenium in healthy individuals living in Tehran. Nutr J 4:32-35
24. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169
25. Arner ES, Zhong L, Holmgren A (1999) A preparation and assay of mammalian thioredoxin and thioredoxin reductase. Methods Enzymol 300:226-239
26. Das K, Samanta L, Chainy GBN (2000) A modified spectrophotometric assay of superoxide dismutase using nitrite formation by superoxide radicals. Indian J Biochem Bio 37:201-204
27. Calberg I, Mannervik J (1985) Glutathione reductase. Methods Enzymol 113:484-490
28. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121-126
29. Lobarzewski J, Ginalska G (1995) Industrial use of soluble or immobilized plant peroxidases. Plant peroxidase Newsletter 6:3-7
30. Balinsky D, Bernstein RR (1963) The purification and properties of glucose-6-phosphate dehydrogenase from human erythrocytes. Biochim Biophy Acta 67:313-315
31. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophy 82:70-77
32. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302-310
33. Roher AE, Esh CL, Kokjohn TA et al (2009) Aβ peptides in human plasma and their significance for Alzheimer's disease. Alzheimers Dement 5:18-29
34. Toledo JB, Shaw LM, Trojanowski JQ (2013) Plasma amyloid beta measurements-a desired but elusive Alzheimer's disease biomarker. Alzheimers Res Ther 5:8-17
35. Klapinska B, Poprezecki S, Danch A et al (2005) Blood selenium concentration of residents of upper Silesia: relation to age and gender. Polish J of Environ Stud 15:753-758 (Pubitemid 44742103)
36. van Eersel J, KeYD, Liu X et al (2010) Sodium selenate mitigates tau pathology, neurodegeneration and functional deficits in Alzheimer's disease. Proc Natl Acad Sci U S A 107:13888-13893
37. Bellinger FP, He Q, Bellinger MT et al (2008) Association of selenoprotein P with Alzheimer 's pathology in human cortex. J Alzheimers Dis 15:465-472
38. Strozyk D, Launer LJ, Adlard PA et al (2009) Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid. Neurobiol Aging 30:1069-1077
39. Naziroǧlu M (2009) Role of selenium on calcium signalling and oxidative stress induced molecular pathways in epilepsy. Neurochem Res 34:2181-2191
40. Gil L, Siems W, Mazurek B et al (2006) Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radial Res 40:495-505